TABLE. Demographic and clinic aspects of study population.
| Parameters | CTL | HHC | PB | MB | T1R | T2R |
| Participants (n) | 18 | 6 | 14 | 13 | 12 | 11 |
| Sex | ||||||
| Man (%) | 8 (44.4) | 2 (33.3) | 6 (42.9) | 7 (53.8) | 9 (75.0) | 10 (90.9) |
| Women (%) | 10 (55.6) | 4 (66.7) | 8 (57.1) | 6 (46.2) | 3 (25) | 1 (9.1) |
| Age, median (min-max) | 38 (22-56) | 37 (21-53) | 38 (19-47) | 48 (34-65) | 49 (21-62) | 45 (27-64) |
| BI, median (min-max) | - | - | 0 (0-0) | 2.8 (2.5-5.5) | 0 (0-3.5) | 3.0 (2.8-5.0) |
| Number of lesions, median (min-max) | - | - | 3.5 (0-20) | 20 (1-20) | 20 (1-30) | 20 (20-30) |
| Number of affected nerves, median (min-max) | - | - | 0 (0-3) | 1.5 (0-3) | 2 (0-3) | 2 (0-2) |
CTL: control group of subjects without medical history of leprosy; HHC: households contacts group; PB: patients with paucibacillary leprosy; MB: patients with multibacillary leprosy; T1R: patients with type 1 leprosy reaction (Reversal reaction); T2R: patients with type 2 leprosy reaction (Erythema nodosum leprosum); BI: bacilloscopic index.